苯磺酸左旋氨氯地平结构式
|
常用名 | 苯磺酸左旋氨氯地平 | 英文名 | Levamlodipine |
|---|---|---|---|---|
| CAS号 | 103129-82-4 | 分子量 | 567.051 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 527.2±50.0 °C at 760 mmHg | |
| 分子式 | C20H25ClN2O5 | 熔点 | 102-104°C | |
| MSDS | N/A | 闪点 | 272.6±30.1 °C |
苯磺酸左旋氨氯地平用途Levamlodipine ((S)-Amlodipine) 是一种功能强大的二氢吡啶钙通道阻滞剂,具有舒张血管的作用,可用于高血压、心绞痛的治疗。 |
| 中文名 | 左旋氨氯地平 |
|---|---|
| 英文名 | (S)-Amlodipine |
| 中文别名 | s-氨氯地平 | (4S)-2-[(2-氨基乙氧基)甲基]-4-(2-氯苯基)-1,4-二氢-6-甲基-3,5-吡啶二甲酸 3-乙基 5-甲基酯 | (S)-氨氯地平 | 苯磺酸左旋氨氯地平 |
| 英文别名 | 更多 |
| 描述 | Levamlodipine ((S)-Amlodipine) 是一种功能强大的二氢吡啶钙通道阻滞剂,具有舒张血管的作用,可用于高血压、心绞痛的治疗。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
Calcium channel[1]. |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 527.2±50.0 °C at 760 mmHg |
| 熔点 | 102-104°C |
| 分子式 | C20H25ClN2O5 |
| 分子量 | 567.051 |
| 闪点 | 272.6±30.1 °C |
| 精确质量 | 566.148987 |
| PSA | 99.88000 |
| LogP | 4.16 |
| InChIKey | HTIQEAQVCYTUBX-KRWDZBQOSA-N |
| SMILES | CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.546 |
| 储存条件 | -20°C Freezer |
| 危害码 (欧洲) | Xi |
|---|
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:WO2008/51056 A1, ; Page/Page column 5; 7; 8 ; |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~64%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Goldmann; Stoltefuss; Born Journal of Medicinal Chemistry, 1992 , vol. 35, # 18 p. 3341 - 3344 |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 29, # 9 p. 1696 - 1702 |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:WO2010/148191 A2, ; Page/Page column 45-49; 59 ; |
|
~%
苯磺酸左旋氨氯地平 103129-82-4 |
| 文献:Journal of Medicinal Chemistry, , vol. 35, # 18 p. 3341 - 3344 |
| 苯磺酸左旋氨氯地平上游产品 2 | |
|---|---|
| 苯磺酸左旋氨氯地平下游产品 0 | |
| Norvasc |
| 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (4S)-, benzenesulfonate (1:1) |
| l-Amlodipine |
| Levamlodipine Besylate Tablets |
| LevoaMlodipine |
| 3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester |
| T6M DHJ B1O2Z CVO2 DR BG& EVO1 F1 |
| 2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl Ester |
| Lodien |
| UNII:1J444QC288 |
| 3-Ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Levamlodipine |
| 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester |
| 3-Ethyl 5-methyl (4S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate benzenesulfonate (1:1) |
| Amlodipine |
| Levoamlodipine Besylate |
| 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| 3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate |